journal
Journals Journal of Clinical Movement D...

Journal of Clinical Movement Disorders

https://read.qxmd.com/read/35113508/continuous-subcutaneous-apomorphine-infusion-allowing-awake-deep-brain-stimulation-in-a-parkinson-s-disease-patient
#1
JOURNAL ARTICLE
Francesca Spagnolo, Francesco Romeo, Piermassimo Proto, Augusto Maria Rini, Emanuela Leopizzi, Andrea Tedesco, Marco Frizzi, Bruno Passarella
BACKGROUND: Subthalamic Deep Brain Stimulation (DBS) have demonstrated in the last decades to determine an important clinical improvement in advanced and selected Parkinson's disease (PD) patients. However, only a minority of parkinsonian patients meet the criteria to undergo DBS, and the surgical procedure itself is often stressful, especially for patients experiencing severe OFF state. Subcutaneous Apomorphine continuous administration is suitable as an adjunctive therapy capable of improving a suboptimal DBS result...
April 9, 2021: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/32884828/abobotulinumtoxina-using-2-ml-dilution-500%C3%A2-u-2-ml-maintains-durable-improvement-across-multiple-treatment-cycles
#2
JOURNAL ARTICLE
Khashayar Dashtipour, Stefan Wietek, Bruce Rubin, Pascal Maisonobe, Laxman Bahroo, Richard Trosch
BACKGROUND: Cervical dystonia (CD), the most common focal dystonia, is a chronic neurological movement disorder characterized by sustained involuntary contractions of the neck muscles, leading to abnormal postures. AbobotulinumtoxinA (aboBoNT-A) was approved in the US initially as a 500 U per 1-mL dilution and subsequently, as a 500 U/2-mL dilution (or 250 U/mL), thereby providing clinicians with more flexible dosing options to better meet individual patient needs...
2020: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/32782815/potential-impact-and-challenges-associated-with-parkinson-s-disease-patient-care-amidst-the-covid-19-global-pandemic
#3
JOURNAL ARTICLE
Ali Elbeddini, Anthony To, Yasamin Tayefehchamani, Cindy Wen
BACKGROUND: COVID-19 has made itself known to health care providers and families across the world in a matter of months. While primarily a respiratory disorder, it has also been shown to cause neurological symptoms, which can be a concern for Parkinson's disease (PD) patients. Although PD is not as common as other conditions such as cardiovascular diseases, it affects millions of patients around the world whose care has been affected by the global pandemic. OBJECTIVES: The aim of this review is to provide insight into the direct and indirect associations between COVID-19 and PD patient care...
2020: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/32742709/correction-to-economic-evaluation-of-abobotulinumtoxina-vs-onabotulinumtoxina-in-real-life-clinical-management-of-cervical-dystonia
#4
V P Misra, N Danchenko, P Maisonobe, J Lundkvist, M Hunger
[This corrects the article DOI: 10.1186/s40734-020-0083-0.].
2020: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/32377368/objective-measurement-in-parkinson-s-disease-a-descriptive-analysis-of-parkinson-s-symptom-scores-from-a-large-population-of-patients-across-the-world-using-the-personal-kinetigraph%C3%A2
#5
JOURNAL ARTICLE
Rajesh Pahwa, Filip Bergquist, Malcolm Horne, Michael E Minshall
BACKGROUND: The Personal KinetiGraph® (PKG®) Movement Recording System provides continuous, objective, ambulatory movement data during routine daily activities and provides information on medication compliance, motor fluctuations, immobility, and tremor for patients with Parkinson's disease (PD). Recent evidence has proposed targets for treatable symptoms. Indications for PKG vary by country and patient selection varies by physician. METHODS: The analyses were based upon 27,834 complete and de-identified PKGs from January 2012 to August 2018 used globally for routine clinical care...
2020: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/32280482/quantification-of-tremor-using-consumer-product-accelerometry-is-feasible-in-patients-with-essential-tremor-and-parkinson-s-disease-a-comparative-study
#6
JOURNAL ARTICLE
Emilie M J van Brummelen, Dimitrios Ziagkos, Wadim M I de Boon, Ellen P Hart, Robert J Doll, Teppo Huttunen, Petteri Kolehmainen, Geert Jan Groeneveld
BACKGROUND: To quantify pharmacological effects on tremor in patients with essential tremor (ET) or Parkinson's Disease (PD), laboratory-grade accelerometers have previously been used. Over the last years, consumer products such as smartphones and smartwatches have been increasingly applied to measure tremor in an easy way. However, it is unknown how the technical performance of these consumer product accelerometers (CPAs) compares to laboratory-grade accelerometers (LGA). This study was performed to compare the technical performance of CPAs with LGA to measure tremor in patients with Parkinson's Disease (PD) and essential tremor (ET)...
2020: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/32257364/vitamin-b12-measurements-across-neurodegenerative-disorders
#7
JOURNAL ARTICLE
Nijee S Luthra, Ariane H Marcus, Nancy K Hills, Chadwick W Christine
BACKGROUND: Vitamin B12 deficiency causes a number of neurological features including cognitive and psychiatric disturbances, gait instability, neuropathy, and autonomic dysfunction. Clinical recognition of B12 deficiency in neurodegenerative disorders is more challenging because it causes defects that overlap with expected disease progression. We sought to determine whether B12 levels at the time of diagnosis in patients with Parkinson's disease (PD) differed from those in patients with other neurodegenerative disorders...
2020: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/32071728/economic-evaluation-of-abobotulinumtoxina-vs-onabotulinumtoxina-in-real-life-clinical-management-of-cervical-dystonia
#8
JOURNAL ARTICLE
V P Misra, N Danchenko, P Maisonobe, J Lundkvist, M Hunger
BACKGROUND: Botulinum neurotoxins type A (BoNT-As) are commonly used treatments for cervical dystonia (CD). Clinical trials have demonstrated the benefits of them in these patients, but data from real-life clinical practice as well as comparative data on the cost and outcome of different BoNT-A formulations are limited. The aim of this study was to compare abobotulinumtoxinA (aboBoNT-A) and onabotulinumtoxinA (onaBoNT-A) on their clinical outcomes and drug costs in real-life clinical practice...
2020: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/32042435/case-study-on-the-use-of-intensive-pediatric-neurorehabilitation-in-the-treatment-of-kernicterus
#9
Jessie Mann, Dory A Wallace, Stephanie DeLuca
Background: Kernicterus Spectrum Disorder (KSD) is the result of prolonged bilirubin toxicity resulting in widespread neurological injury. Once the bilirubin levels are normalized the encephalopathy becomes static, however the consequences of the injury can have life-long effects. The sequelae of KSD include motor impairments, auditory deficits, dental dysplasia, and potentially cognitive impairments. While KSD is a rare diagnosis, particularly in developed countries, there is evidence that there may be a global increase in incidence (Hansen, Semin Neonatol 7:103-9, 2002; Johnson, J Perinatol 29:S25-45, 2009; Kaplan etal...
2020: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/31890235/a-case-of-gerstmann-straussler-scheinker-gss-disease-with-supranuclear-gaze-palsy
#10
Nicole A Ufkes, Craig Woodard, Marian L Dale
BACKGROUND: Gerstmann-Straussler-Scheinker disease (GSS), an autosomal dominant prion disorder, usually presents as a slowly progressive cerebellar ataxia followed by later cognitive decline. We present a member of the GSS Indiana Kindred with supranuclear palsy, a less common feature in GSS. CASE PRESENTATION: A 42-year-old man presented with 12 months of progressive gait and balance difficulty. Exam was notable for ataxia and cerebellar eye movement abnormalities...
2019: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/31844536/-feasibility-and-utility-of-a-simple-computerized-test-for-measuring-saccade-latency-in-progressive-supranuclear-palsy-a-proof-of-concept-study
#11
JOURNAL ARTICLE
Marian L Dale, Emmi P Scott, Saher Khalid, Andrew S Eiseman, Travis H Turner
BACKGROUND: Reliable detection of slowed vertical saccades may help discriminate progressive supranuclear palsy (PSP) from the subset of Parkinson's disease patients who lack tremor (akinetic-rigid or PD-postural instability and gait disorder PIGD subtype), and from age-related oculomotor changes. We investigated the feasibility of a camera-less computerized behavioral saccade latency paradigm previously validated in PD to discriminate probable PSP-Richardson syndrome (PSP-RS) from PD-PIGD and age-matched controls...
2019: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/31754440/tongue-involvement-in-embouchure-dystonia-new-piloting-results-using-real-time-mri-of-trumpet-players
#12
JOURNAL ARTICLE
Soenke J Hellwig, Peter W Iltis, Arun A Joseph, Dirk Voit, Jens Frahm, Erwin Schoonderwaldt, Eckart Altenmüller
BACKGROUND: The embouchure of trumpet players is of utmost importance for tone production and quality of playing. It requires skilled coordination of lips, facial muscles, tongue, oral cavity, larynx and breathing and has to be maintained by steady practice. In rare cases, embouchure dystonia (EmD), a highly task specific movement disorder, may cause deterioration of sound quality and reduced control of tongue and lip movements. In order to better understand the pathophysiology of this movement disorder, we use real-time MRI to analyse differences in tongue movements between healthy trumpet players and professional players with embouchure dystonia...
2019: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/31410292/erratum-publisher-correction-to-journal-of-clinical-movement-disorders-volume-6
#13
(no author information available yet)
[This corrects the article DOI: 10.1186/s40734-019-0077-y.].
2019: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/31367459/huntington-s-disease-a-forensic-risk-factor-in-women
#14
Elvina May-Yin Chu, Mari O'Neill, Debasish Das Purkayastha, Caroline Knight
BACKGROUND: Huntington's disease (HD) is an autosomal dominant, neurodegenerative disorder. Associated cognitive deficits including impulsivity and disinhibition are the same factors that also predispose to forensic risk. Men tend to be perpetrators of more severe violent behaviours than women and women are less likely than men to be arrested for violence. This finding is not applicable in the case of women with Huntington's disease and explored in the three clinical cases of women with HD and their forensic histories that are subsequently described...
2019: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/31183157/telepsychiatry-for-patients-with-movement-disorders-a-feasibility-and-patient-satisfaction-study
#15
JOURNAL ARTICLE
Andreea L Seritan, Melissa Heiry, Ana-Maria Iosif, Michael Dodge, Jill L Ostrem
BACKGROUND: Telemedicine is a convenient health service delivery modality for patients with movement disorders, including Parkinson's disease (PD), but is currently underutilized in the management of associated psychiatric symptoms. This study explored the feasibility of and patient satisfaction with telepsychiatry services at an academic movement disorders center. METHODS: All patients seen by telepsychiatry between January and December 2017 at the UCSF Movement Disorders and Neuromodulation Center were invited to participate...
2019: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/30899540/transcranial-magnetic-stimulation-therapy-for-focal-leg-dystonia-a-case-report
#16
Kush Sharma, Alberto Cucca, Andrea Lee, Shashank Agarwal, Steven Joel Frucht, Milton Cesar Biagioni
BACKGROUND: Dystonia is a debilitating disease that causes abnormal, often repetitive, movements, postures or both. The pathophysiology is unknown but related to loss of neuronal inhibition, aberrant sensorimotor integration, and/or derangements of synaptic plasticity. Current treatments include pharmacotherapy, botulinum toxin injections and deep brain stimulation (DBS). The response to these treatments are often limited and carry the risk of side effects requiring alternative therapies such as non-invasive brain stimulation...
2019: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/30479824/correction-to-medical-treatment-of-dystonia
#17
Pichet Termsarasab, Thananan Thammongkolchai, Steven J Frucht
[This corrects the article DOI: 10.1186/s40734-016-0047-6.].
2018: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/30397507/characterization-of-vitamin-d-supplementation-and-clinical-outcomes-in-a-large-cohort-of-early-parkinson-s-disease
#18
JOURNAL ARTICLE
Nijee S Luthra, Soeun Kim, Yunxi Zhang, Chadwick W Christine
BACKGROUND: Vitamin D (VitD) deficiency is common in Parkinson's disease (PD) and has been raised as a possible PD risk factor. In the past decade, VitD supplementation for potential prevention of age related conditions has become more common. In this study, we sought to characterize VitD supplementation in early PD and determine as an exploratory analysis whether baseline characteristics or disease progression differed according to reported VitD use. METHODS: We analyzed data from the National Institutes of Health Exploratory Trials in Parkinson's Disease (NET-PD) Long-term study (LS-1), a longitudinal study of 1741 participants...
2018: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/30123518/sca2-presenting-as-a-focal-dystonia
#19
Nan Cheng, Heather M Wied, James J Gaul, Lauren E Doyle, Stephen G Reich
BACKGROUND: Spinocerebellar ataxia 2 (SCA2) is an autosomal dominant neurodegenerative disorder caused by CAG repeat expansions in ATXN2 on chromosome 12q24. Patients present with adult-onset progressive gait ataxia, slow saccades, nystagmus, dysarthria and peripheral neuropathy. Dystonia is known to occur as SCA2 advances, but is rarely the presenting symptom. CASE PRESENTATION: A 43-year-old right handed woman presented with focal dystonia of the right hand which started two years earlier with difficulty writing...
2018: Journal of Clinical Movement Disorders
https://read.qxmd.com/read/30123517/inpatient-care-for-stiff-person-syndrome-in-the-united-states-a-nationwide-readmission-study
#20
JOURNAL ARTICLE
James A G Crispo, Dylan P Thibault, Yannick Fortin, Allison W Willis
Background: Stiff person syndrome (SPS) is a progressive neurological disorder characterized by axial muscle rigidity and involuntary spasms. Autoimmune and neoplastic diseases are associated with SPS. Our study objectives were to describe inpatient care for SPS in the United States and characterize 30-day readmissions. Methods: We queried the 2014 Nationwide Readmission Database for hospitalizations where a diagnosis of SPS was recorded. For readmission analyses, we excluded encounters with missing length of stay, hospitalization deaths, and out-of-state and December discharges...
2018: Journal of Clinical Movement Disorders
journal
journal
52767
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.